-transparent.png){kind=logo}
Seven patients with type II idiopathic mixed cryoglobulinemia were treated with recombinant human leukocyte interferon (alpha interferon). In all of them, a conspicuous reduction of circulating cryoglobulins was noted, together with a definite, remarkable improvement of the clinical pattern. The immunologic parameters (natural killer cell activity and phagocytosis, among others) improved as well; side effects were usually mild and transient. Increases in the cryoglobulin level occurred in a few cases, but they were at least partly sensitive to readministration of alpha interferon treatment. The favorable results obtained in these cases of idiopathic cryoglobulinemia seem to be consistent and prolonged.
L Bonomo, and
M Casato, and
A Afeltra, and
D Caccavo
June 1994,
Journal of gastroenterology,
L Bonomo, and
M Casato, and
A Afeltra, and
D Caccavo
November 1991,
The American journal of medicine,
L Bonomo, and
M Casato, and
A Afeltra, and
D Caccavo
February 1998,
Journal of hepatology,
L Bonomo, and
M Casato, and
A Afeltra, and
D Caccavo
July 1997,
Journal of hepatology,
L Bonomo, and
M Casato, and
A Afeltra, and
D Caccavo
January 1990,
European journal of haematology. Supplementum,
L Bonomo, and
M Casato, and
A Afeltra, and
D Caccavo
January 1995,
Clinical and experimental rheumatology,
L Bonomo, and
M Casato, and
A Afeltra, and
D Caccavo
May 2003,
Blood,
L Bonomo, and
M Casato, and
A Afeltra, and
D Caccavo
January 2002,
Clinical and experimental rheumatology,
L Bonomo, and
M Casato, and
A Afeltra, and
D Caccavo
November 1992,
Recenti progressi in medicina,
L Bonomo, and
M Casato, and
A Afeltra, and
D Caccavo
May 1993,
Medicina clinica,
